Zhang, Shuaipan
Kong, Lingjun
Zhu, Qingguang
Wu, Zhiwei
Li, Jianhua
Fang, Min
Sun, Wuquan
Cheng, Yanbin
Xu, Shanda
Guo, Guangxin
Zhou, Xin
Lv, Zhizhen
Funding for this research was provided by:
Shenkang Three-Year Action Plan "Clinical Skills Enhancement Project for Major Diseases" (16CR1023A)
National Key Clinical Difficult Diseases Clinical Collaborative Pilot Construction Project - Osteoarticular Degenerative Disease (ZY(2018-2020)-FWTX-2005)
Shanghai Further accelerate the three-year action plan for the development of Chinese medicine (ZY (2018-2020)-CCCX-2004-02)
Shanghai Health and Family Planning Commission Chinese Medicine Research Project (2018LP040)
Shanghai Health and Family Planning System Outstanding Young Medical Talents (2018YQ004)
Chinese Society of Chinese Medicine Youth Encouraging Talents Program (QNRC2-A01)
Article History
Received: 16 July 2019
Accepted: 21 February 2020
First Online: 17 March 2020
Ethics approval and consent to participate
: Ethics approval was requested from and granted by the ethics committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, which is affiliated with Shanghai University of Traditional Chinese Medicine (reference 2019-035). Informed consent will be obtained from all study participants before any data collection by the clinical trial communicator. All participants will provide their consent in writing. Nobody except the investigators have access to the final data.
: This section is not applicable, because no personal information is provided in this article.
: The authors declare that they have no competing interests.